FDA Expands Use of Remote Patient Monitoring During COVID-19 Emergency

FDA COVID 19 Remote monitoring
Image: Wright-Patterson AFB
The U.S. Food and Drug Administration (FDA) has issued a new policy that allows manufacturers of certain FDA-cleared non-invasive, vital sign-measuring devices to expand their use so that health care […]
To access this page, watch the live streams and videos on-demand, please register free of charge to the WT | Wearable Technologies COMMUNITY.
Previous articleAktiia Raises CHF 6 Million in Funding to Market its Cuffless Optical Blood Pressure Monitor
Next articleViTrack: Cuffless Wearable for Continuous, Non-Invasive Blood Pressure Monitoring
Cathy Russey () is Online Editor at WT | Wearable Technologies and specialized in writing about the latest medical wearables and enabling technologies on the market. Cathy can be contacted at info(at)wearable-technologies.com.